Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired hypothalamic obesity.

Osteoporosis treatment was associated with reduced hospitalization and mortality risks following fragility fracture after 80 years of age.

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.

PCOS was associated with an increased risk for vascular events including stroke among women with thrombotic disease, and a lower mean age.

COCPs were associated with improved obesity outcomes among patients with hyperandrogenic PCOS, but metformin added little benefit.

ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...

MASLD rates have decreased, whereas liver fibrosis and cirrhosis rates have increased among US patients with type 2 diabetes since 2017.

There is increased risk for atrial fibrillation in patients with implanted devices exposed to hot outdoor temperatures.

Diabetes remission was more likely and laparoscopic surgery was less likely among women than men with paragangliomas and pheochromocytomas.

Compared with those with overweight and normal weight, people with obesity were more likely to report financial hardship and food insecurity.

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...

Traditional cardiovascular risk assessment tools underperform among individuals with metabolic dysfunction-associated steatotic liver disease.